EN
HI
Bliss GVS Pharma Chart
Bliss GVS Pharma Share Key Metrics
Volume
40.45 L
Market Cap
2894.28 CR
LTQ@LTP
4@273.59
ATP
272.17
Var Margin
27.56 %
Circuit Range
207.05-310.57
Delivery %
43.32 %
Value
110.08 CR
ASM/GSM
No
Market Lot
1
Summary
Bliss GVS Pharma share price stands at ₹273.59 at 22 Apr, 2026 | 15:59. The stock Bliss GVS Pharma intraday movement has stayed between ₹260.00 and ₹276.95, while on a 52-week basis it has fluctuated from ₹109.03 to ₹276.95.
In terms of trading activity, Bliss GVS Pharma has recorded a volume of 4044628 shares. The Bliss GVS Pharma has a market cap of ₹105788972. The stock’s Average Traded Price (ATP) stands at ₹27217, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 4, 27359.
The Bliss GVS Pharma operates within a circuit range of ₹207.05-310.57 – ₹207.05-310.57, with a Value of ₹110.08 CR. The Delivery Percentage for the day is 43.32%. Additionally, Bliss GVS Pharma currently falls under the No framework, and trades with a market lot size of 1.
Bliss GVS Pharma Fundamentals
View MoreP/E Ratio
25.08
P/B Ratio
2.36
Div. Yield
0.19
Sector P/E
63.84
Sector P/B
3.48
Sec. Div. Yield
0.57
Bliss GVS Pharma Resistance and Support
Pivot 258.01
Resistance
First Resistance
265.02
Second Resistance
271.24
Third Resistance
278.25
Support
First Support
251.79
Second Support
244.78
Third Support
238.56
Bliss GVS Pharma Corporate Actions
| Date | Agenda |
|---|---|
| 2026-02-10 | Quarterly Results & Interim Dividend |
| 2025-11-06 | Quarterly Results |
| 2025-07-29 | Quarterly Results |
| 2025-05-12 | Audited Results & Final Dividend |
| 2025-01-28 | Quarterly Results & Others |
Bliss GVS Pharma News
Bliss GVS Pharma Limited
Bliss GVS Pharma announced a postal ballot for shareholders to vote on the appointment of Mr. Vijayanarayanan Mahadevan and Mr. Deepak Rameshchandra Shah as Non-Executive Independent Directors for five years. The e-voting period runs from April 10, 2026 to May 09, 2026, with results expected by May 12, 2026.
Apr 10 2026 16:04:00
Bliss GVS Pharma Limited
Bliss GVS Pharma will conduct a postal ballot for the appointment of two Non-Executive and Independent Directors, Mr. Vijayanarayanan Mahadevan and Mr. Deepak Rameshchandra Shah. Both are proposed for five-year terms from April 3, 2026, with voting open until May 9, 2026.
Apr 09 2026 18:04:00
Read More
About Bliss GVS Pharma
NSE : 19265
BSE : 506197
ISIN : INE416D01022
Bliss GVS Pharma Management
| Name | Position |
|---|---|
| Aditi Bhatt | Company Secretary & Compliance Officer |
| Nandkumar chodankar | Chairman |
Bliss GVS Pharma Similar Stocks
RPG Life Sciences Ltd.
1965.20
-33.50 (1.68%)
Aarti Drugs Ltd.
366.95
5.35 (1.48%)
Gujarat Themis Biosyn Ltd.
328.02
-2.81 (0.85%)
Gufic Biosciences Ltd.
290.25
-0.55 (0.19%)
Orchid Pharma Ltd.
551.95
-2.90 (0.52%)
Dishman Carbogen Amcis Ltd.
170.79
1.23 (0.73%)
IOL Chemicals And Pharmaceuticals Ltd.
94.13
2.90 (3.18%)
Dr Agarwals Eye Hospital Ltd.
4852.80
-8.25 (0.17%)
Unichem Laboratories Ltd.
370.00
23.40 (6.75%)
Bliss GVS Pharma FAQs
The Buying Price of Bliss GVS Pharma share is 273.59 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.
To buy Bliss GVS Pharma stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Bliss GVS Pharma, choose your preferred order type, and place the trade.
The Price-to-earnings (P/E) ratio of Bliss GVS Pharma shares is 25.08. You can compare it with the sector average for relative valuation.
The Price to Book (P/B) ratio Bliss GVS Pharma shares is 2.36. Useful to assess the stock's value relative to its book value.
To assess Bliss GVS Pharma’s valuation compare Sector P/E, P/B which are 63.84 & 3.48 with sector averages, along with growth rates and financial metrics.
The Market Cap of Bliss GVS Pharma is 2894.28 CR. It indicates the company's size category and trading liquidity.
The 52 week high and low prices of Bliss GVS Pharma share price is 276.95 & 109.03. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.
Bliss GVS Pharma belongs to the Healthcare sector.
